CORC

在结果中检索

CORC

浏览/检索结果: 共218条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Cross-lingual text image recognition via multi-task sequence to sequence learning 会议论文
Milan, Italy, 2021-1-10
作者:  Chen, Zhuo;  Yin, Fei;  Zhang, Xu-Yao;  Yang, Qing;  Liu, Cheng-Lin
收藏  |  浏览/下载：16/0  |  提交时间：2021/07/01
Contextual Stroke Classification in Online Handwritten Documents with Graph Attention Networks 会议论文
澳大利亚,悉尼, 2019-9
作者:  Jun-Yu Ye;  Yan-Ming Zhang;  Qing Yang;  Cheng-Lin Liu
收藏  |  浏览/下载：13/0  |  提交时间：2021/03/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
A New Trademark Detection Method via Trademark Confidence Score of MSERs 会议论文
Guangzhou, China, May 10, 2019 - May 13, 2019
作者:  Yang, Zheng;  Jie,Liu;  Yuan, Zhang;  Shuwu,Zhang;  Qing,Li
收藏  |  浏览/下载：35/0  |  提交时间：2019/10/09
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：142/0  |  提交时间：2019/12/02
A method for optimizing and designing high isolation level Cassegrainian optical antenna 会议论文
Chengdu, China, 2018-06-26
作者:  Zhou, Shao-Pan;  Xue, Bin;  Yang, Jian-Feng;  Liu, Sheng-Run;  Chen, Guo-Qing
收藏  |  浏览/下载：24/0  |  提交时间：2019/03/22
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace